Data as of May 24
| -0.0049 / -5.16%|
The 1 analysts offering 12-month price forecasts for Cardium Therapeutics Inc have a median target of 0.40, with a high estimate of 0.40 and a low estimate of 0.40. The median estimate represents a +344.44% increase from the last price of 0.09.
The current consensus among 1 polled investment analysts is to Buy stock in Cardium Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.